Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias

NCT01780311 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2013-01-31

No results posted yet for this study

Summary

A randomized, parallel, open study comparing catheter ablation versus antiarrhythmic drugs for outflow tract ventricular arrhythmias

Conditions

  • Ventricular Tachycardia
  • Ventricular Premature Complexes

Interventions

DRUG

antiarrhythmic drugs (Flecainide or Propafenone or Sotalol)

PROCEDURE

Catheter Ablation

Sponsors & Collaborators

  • Ospedale San Donato

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01780311 on ClinicalTrials.gov